ASML vs CXM

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

CXM exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and no Altman Z-Score provided. Despite consistent earnings beats and a clean balance sheet (Debt/Equity 0.08), the stock is trading at a significant premium to its Graham Number ($2.20) and Intrinsic Value ($0.63). Severe price erosion across all timeframes, combined with aggressive insider selling and a -90% YoY earnings collapse, outweighs the optimistic forward P/E and PEG ratio.